DCM Shriram Industries Ltd
NSE: DCMSRIND BSE: 523369Energy
DCM Shriram Industries Ltd is primarily engaged in production and sale of sugar, alcohol, power, chemicals, Drones (UAV) and industrial fibers.
₹39.7
52W: ₹31.9 — ₹63.1
PE 9.17 · Book ₹69 · -42% vs bookMarket Cap₹518 Cr
Stock P/E9.17Price to Earnings
ROCE13.8%Return on Capital
ROE11.9%Return on Equity
Div. Yield5.06%Face Value ₹2
Strengths
- +Company has reduced debt.
- +Stock is trading at 0.58 times its book value
- +Stock is providing a good dividend yield of 5.10%.
Weaknesses
- −The company has delivered a poor sales growth of 2.71% over past five years.
- −Company has a low return on equity of 12.1% over last 3 years.
Shareholding Pattern
Promoters50.11%
FIIs1.17%
DIIs12.72%
Public35.91%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.11% | 50.11% | 50.11% | 50.11% | 50.11% | 50.11% | 50.11% | 50.11% |
| FIIs | 2.23% | 2.15%▼0.1 | 2%▼0.1 | 1.84%▼0.2 | 1.78%▼0.1 | 1.66%▼0.1 | 1.49%▼0.2 | 1.17%▼0.3 |
| DIIs | 7.71% | 7.51%▼0.2 | 11.96%▲4.5 | 12.39%▲0.4 | 13.32%▲0.9 | 12.78%▼0.5 | 12.72%▼0.1 | 12.72% |
| Public | 39.93% | 40.22%▲0.3 | 35.92%▼4.3 | 35.66%▼0.3 | 34.78%▼0.9 | 35.46%▲0.7 | 35.57%▲0.1 | 35.91%▲0.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 580 | 468 | 512 | 554 | 533 | 261 | 472 | 499 | 336 | 258 |
| Expenses | 535 | 416 | 442 | 492 | 487 | 247 | 423 | 454 | 322 | 233 |
| Operating Profit | 46 | 52 | 69 | 62 | 46 | 14 | 48 | 45 | 13 | 25 |
| OPM % | 8% | 11% | 14% | 11% | 9% | 5% | 10% | 9% | 4% | 10% |
| Net Profit | 20 | 29 | 38 | 31 | 22 | 8 | 24 | 18 | 3 | 12 |
| EPS ₹ | 2.32 | 3.3 | 4.41 | 3.56 | 2.58 | 0.88 | 2.72 | 2.04 | 0.4 | 0.88 |
AI Insights
Revenue Trend
TTM revenue at ₹1,563Cr, down 23.8% YoY. OPM at 8%.
Debt Position
Borrowings at ₹287Cr. Debt-to-equity ratio: 0.33x. Healthy balance sheet.
Capex Cycle
CWIP at ₹31Cr (5% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 12.72% (+4.89pp change). FIIs: 1.17% (+1.04pp change). Promoters hold 50.11%.
Margin & Efficiency
ROCE declining from 15% (Mar 2014) to 14% (Mar 2025). Working capital days: 40.
Valuation
PE 9.17x with 13.8% ROCE. Price is -42% above book value of ₹69. Dividend yield: 5.06%.
Recent Announcements
- Board Meeting Intimation for Intimation Of Board Meeting 14 May - Board meets on 20 May 2026 to approve FY26 audited results and consider dividend.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st March 2026.
- Announcement under Regulation 30 (LODR)-Credit Rating 7 Apr - CARE downgraded bank facilities to A-/A2+ and FD programme to A- on April 1, 2026.
- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 2 Apr
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 2 Apr
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse